A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer.

Biotechnology

Pharmaceutical

Ratio Therapeutics

Jack Hoppin

Robyn T.

Bill Cupelo

Susan K. Whoriskey

Allan Green

John Babich

Kelly Orcutt

Stephen Dimagno

Matthias Friebe

Shawn Hillier

John M. Garvey

Jacob Hesterman

The Leadership Team at Ratio Therapeutics spearheads the strategic direction and overall management of the company. They oversee critical functions such as business development, legal and regulatory compliance, technological innovation, scientific research, clinical translation, and operational efficiency, ensuring the successful development of targeted radiotherapeutics for cancer treatment.

Leadership Team

Scientific Research Team

Operations Team

Leadership Team

About

Team members

Other teams at Ratio Therapeutics

Scientific Research Team

Operations Team